JaredStevenNielsenMDMBA

Ophthalmology • West Des Moines, IA

Retinal Disease, Uveitis

Vitreoretinal Surgeon, Director Clinical Trials, Director Vitreoretinal Diseases and Surgery Fellowship

Join to view full profile

Dr. Nielsen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Nielsen's full profile

Already have an account?

Office
6200 Westown Parkway
West Des Moines, IA 50266
Phone+1 515-223-6585

Fax+1 515-223-5468
Is this information wrong?

Education & Training

University of IowaMBA, Masters of Business Administration, 2013 - 2018
McGaw Medical Center of Northwestern UniversityFellowship, Surgical Retina and Vitreous, 2005 - 2007
Loyola University Medical CenterResidency, Ophthalmology, 2002 - 2005
University of HawaiiInternship, Transitional Year, 2001 - 2002
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2001

Certifications & Licensure

IA State Medical License 2007 - 2024
IL State Medical License 2002 - 2017
HI State Medical License 2001 - 2002
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
Completed
Phase 2, Phase 3
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
Completed
Phase 3
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) Start of enrollment: 2011 May 01
Completed
Phase 2
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy Start of enrollment: 2012 Mar 01
Completed
Phase 3
An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy Start of enrollment: 2012 May 29
Terminated
Phase 2
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Start of enrollment: 2012 Aug 01
Completed
Phase 3
Treatment for CI-DME in Eyes With Very Good VA Study Start of enrollment: 2013 Oct 01
Completed
Phase 3
Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Completed
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Start of enrollment: 2014 Sep 18
Terminated
Phase 3
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Start of enrollment: 2014 Oct 06
Terminated
Phase 3
A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy Start of enrollment: 2015 Mar 30
Completed
Phase 2
Phase 4 IOP Signals Associated With ILUVIEN® Start of enrollment: 2015 May 06
Completed
Phase 4
PRP vs Bevacizumab for PDR Treatment Start of enrollment: 2016 Feb 01
Completed
Phase 2, Phase 3
Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection Start of enrollment: 2016 Mar 31
Completed
Phase 2
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) Start of enrollment: 2016 Jul 21
Terminated
Phase 3
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) Start of enrollment: 2018 Sep 05
Completed
Phase 3
Effects of Pneumatic Vitreolysis on Vitreomacular Traction Start of enrollment: 2018 Oct 16
Completed
Phase 3
Effects of Pneumatic Vitreolysis on Macular Hole Start of enrollment: 2018 Nov 14
Completed
Not Applicable
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections Start of enrollment: 2018 Oct 30
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

Exuberant Fibrosis over a Susvimo Implant.
Ericksen, C. J., Riley Bylund, Jared S Nielsen, Connor Ericksen> ;Ophthalmology. Retina. 2024 Feb 1
Small-Gauge Vitrectomy for Macular Surgery Using a Systematic Approach to Wound Closure: 27-Gauge vs 25-Gauge.
Thompson, I., Christensen, C., Nielsen, J.> ;Journal of Vitreoretinal Diseases. 2023 Nov 18
Endothelial Graft Orientation Marking Impairing Epiretinal Membrane Surgery Visualization.
William J Johnson, Jared S Nielsen> ;Ophthalmology. 2023 Dec 1
1 citations
High-Dose Aflibercept for Neovascular AMD and DME in Suboptimal Responders to Standard-Dose Aflibercept.
Jared S Nielsen, Carter L Roberts, David D Saggau, Kyle J Alliman> ;Journal of Vitreoretinal Diseases. 2023 Feb 15
1 citations
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA.
Jennifer K Sun, Wesley T Beaulieu, Michele Melia, Frederick L Ferris 3rd, Raj K Maturi, Jared S Nielsen, Sharon D Solomon, Lee M Jampol> ;Retina. 2023 Apr 1
2 citations
Implantation Site of a Port Delivery System With Ranibizumab: Anterior Segment Optical Coherence Tomography Evaluation.
Cory A Christensen, Brian Berger, Shamika Gune, Jared S Nielsen, Ericksen, C. J., Connor J Ericksen> ;Journal of Vitreoretinal Diseases. 2022 Aug 4
6 citations
Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments.
Jennifer K Sun, Kristin Josic, Michele Melia, Adam R Glassman, Clare Bailey, Kakarla V Chalam, Emily Y Chew, Catherine Cukras, Sandeep Grover, Glenn J Jaffe, Richard L...> ;Translational Vision Science & Technology. 2021 Dec 1
23 citations
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
Lloyd Paul Aiello, Allison R. Ayala, Andrew N. Antoszyk, Bambi Arnold-Bush, Carl W. Baker, Neil M. Bressler, Michael J. Elman, Adam R. Glassman, Lee M. Jampol, Michele...> ;JAMA Ophthalmology. 2015 Aug 1
18 citations
MULTIMODAL IMAGING OF WHITE AND DARK WITHOUT PRESSURE FUNDUS LESIONS
Amani A. Fawzi, Jared S. Nielsen, Aranzazu Mateo-Montoya, Thanapong Somkijrungroj, Helen K. Li, John A. Gonzales, Martine Mauget-Faÿsse, Lee M. Jampol> ;Retina. 2014 Dec 1
12 citations
Rifampin induced hepatotoxicity during treatment for chronic central serous chorioretinopathy.
Joel Nelson, David D. Saggau, Jared S. Nielsen> ;Retinal Cases & Brief Reports. 2014 Jan 1
15 citations
Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to ocular histoplasmosis syndrome
Jared S. Nielsen, Tyler A Fick, David D. Saggau, Charles H Barnes> ;Retina. 2012 Mar 1
48 citations
ORAL MIFEPRISTONE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
Jared S. Nielsen, Lee M. Jampol> ;Retina. 2011 Oct 1
4 citations
INTERFERON-β-ASSOCIATED RETINOPATHY.
Javier S. Martinez de Aragon, Jose S. Pulido, Christopher L. Haupert, Christopher F. Blodi, Jared S. Nielsen, Lee M. Jampol> ;Retinal Cases & Brief Reports. 2009 Jan 1
4 citations
A case of chronic severe central serous chorioretinopathy responding to oral mifepristone: update.
Jared S. Nielsen, Arpan Bachhawat, Lee M. Jampol> ;Retina. 2008 Oct 1
22 citations
Mifepristone treatment of chronic central serous chorioretinopathy.
Jared S. Nielsen, Robert N. Weinreb, Lawrence A. Yannuzzi, Lee M. Jampol> ;Retina. 2007 Jan 1
13 citations
Clinicopathologic case report: scleral buckle associated nontuberculous mycobacterial scleritis.
Jared S Nielsen, Steven Blatt, Jay I Perlman, Richard G Gieser> ;Seminars in Ophthalmology. 2004 Sep 1
Join now to see all

Press Mentions

Thousands of Iowans Could Benefit from New Macular Degeneration TreatmentMarch 30th, 2023
14 Ways I Optimize My Health and Energy Every DayOctober 3rd, 2018